Skip to main content
Caplight Logo









Rejuvenation Technologies

Rejuvenation Technologies

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://rejuvenationtech.com/

Last Round

Grant

Sep 4, 2024

Est. Valuation

$1.71M

Total Funding Raised

$18.27M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rejuvenation Technologies is a biotechnology company developing mRNA-based therapeutics and lipid nanoparticle delivery vehicles to extend telomeres and treat age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

mRNA therapeuticslongevity researchlipid nanoparticleLNPage-reversing drugsanti-aging biotechdrug delivery platformTERTtelomerase therapyregenerative medicinepreclinical biotechlongevity escape velocityrejuvenation biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rejuvenation Technologies Comparables

Compare Rejuvenation Technologies with similar companies based on industry and business-model similarity.

Rejuvenation Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Turn Biotechnologies
86%
Oisín Biotechnologies
81%
YouthBio Therapeutics
76%

Rejuvenation Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 4, 2024
GrantAug 1, 2024
GrantJul 26, 2024
SeedSep 6, 2023
GrantJan 26, 2023
Grant
Sep 22, 2022

Rejuvenation Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 79% MoM, reaching 1.5K.

  • Sep 4, 2024

    $325K grant from U.S. Department of Health and Human Services.

Rejuvenation Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rejuvenation Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rejuvenation Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range20
Year Founded2018
Last FundingSep 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?